YE ZHANG

1 clinical trials · Sponsor

Record	Firm	Date
A Phase II Prospective, Open-Label, Randomized, Multicenter Study of Kangfu Spray for the Prevention of Radiation-Induced Oral Mucositis in Patients With Oral Malignancies Receiving Intensity-Modulated Radiotherapy (NCT07538934)	YE ZHANG	2026-07-01

Every clearance here is in the API, with alerts when new ones post.